CRS Trial Reveals Surgery Divide - Summary - MDSpire

CRS Trial Reveals Surgery Divide

  • By

  • Jess Allerton

  • March 18, 2026

  • 3 min

Share

Objective:

To explore patient and clinician experiences in the MACRO trial, focusing on the comparative effectiveness of endoscopic sinus surgery, clarithromycin, and placebo for chronic rhinosinusitis.

Key Findings:
  • ESS showed greater improvement in patient-reported outcomes compared to clarithromycin or placebo, indicating its effectiveness.
  • Patients expressed varied motivations for trial participation, often seeking additional treatment options after previous failures.
  • Some patients viewed surgery positively, while others had concerns about risks, recovery, and the impact on their daily lives.
  • Postoperative experiences varied significantly, with some patients reporting rapid symptom relief and others facing complications.
  • Gastrointestinal symptoms were common among patients receiving clarithromycin, affecting their overall treatment experience.
Interpretation:

The MACRO trial's findings on ESS effectiveness could inform treatment discussions, but implementation faces challenges such as resource limitations, surgical capacity, and patient hesitancy regarding surgery.

Limitations:
  • Small sample size for qualitative interviews limits the generalizability of findings.
  • The context of the trial may not reflect broader patient populations or clinical settings.
Conclusion:

Effective communication and shared decision-making are essential for implementing ESS in clinical practice, alongside adequate health system resources to support surgical care.

Original Source(s)

Related Content